US 10774056
Substituted piperazines as selective HDAC1,2 inhibitors
granted A61PA61P35/00A61P35/02
Quick answer
US patent 10774056 (Substituted piperazines as selective HDAC1,2 inhibitors) held by Regenacy Pharmaceuticals, Inc. expires Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regenacy Pharmaceuticals, Inc.
- Grant date
- Tue Sep 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P35/00, A61P35/02, A61P7/00